Christopher Richard Anzalone, Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 13,187 shares at $65.88 ($872K) on 2026-01-02, disclosed to the SEC on 2026-01-05.
Seasonal sale ($872k) by Chief Executive Officer — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.88 | 7,416 | $489K | 56.0% |
| 2 | $66.39 | 5,771 | $383K | 44.0% |
| Total | $66.10 avg | 13,187 | $872K | 100% |
| Filing → |
| ARWR | SELL | 2025-12-19 | $10.9M | — | Filing → |
| ARWR | SELL | 2025-12-16 | $24.6M | — | Filing → |
| ARWR | SELL | 2025-04-11 | $1.9M | — | Filing → |